These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 10636)

  • 21. Continuous purification of a clotting factor IX concentrate and continuous regeneration by preparative annular chromatography.
    Iberer G; Schwinn H; Josic D; Jungbauer A; Buchacher A
    J Chromatogr A; 2002 Sep; 972(1):115-29. PubMed ID: 12395951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood clotting factor IX. Loss of activity after cleavage of sialic acid residues.
    Chavin SI; Weidner SM
    J Biol Chem; 1984 Mar; 259(6):3387-90. PubMed ID: 6323421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of human Cohn fraction III as a useful source for the simultaneous purification of FIX and FX zymogens.
    Monahan JB; Sodetz JM
    Thromb Res; 1980 Sep; 19(6):743-55. PubMed ID: 7466745
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of plasma collection systems and processing parameters on the quality of factor IX concentrate.
    Farrugia A; Spiers D; Young I; Oates A; Herrington R; Damianos F
    Vox Sang; 1989; 57(1):4-9. PubMed ID: 2800464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved virus safety and purity of a chromatographically produced factor IX concentrate by nanofiltration.
    Hoffer L; Schwinn H; Biesert L; Josic D
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):187-96. PubMed ID: 7581895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A semi-continuous method for purification of factor IX complex from human plasma.
    Tharakan JP; Gee DM; Clark DB
    Vox Sang; 1989; 57(4):233-9. PubMed ID: 2617960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A human spleen factor having capability to degradate fibrin--partial purification and some properties (author's transl)].
    Nagamatsu Y
    Nihon Seirigaku Zasshi; 1978; 40(12):463-71. PubMed ID: 37332
    [No Abstract]   [Full Text] [Related]  

  • 28. The separation of clotting factors. II. Purification of human factor IX by isoelectric focusing.
    Chandra S; Pechet L
    Biochim Biophys Acta; 1973 Dec; 328(2):456-63. PubMed ID: 4776454
    [No Abstract]   [Full Text] [Related]  

  • 29. Purification and some characteristics of the coagulation factor IX from human plasma.
    Osterud B; Flengsrud R
    Biochem J; 1975 Mar; 145(3):469-74. PubMed ID: 1171684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of highly purified clotting factor IX by a combination of different chromatographic methods.
    Hoffer L; Schwinn H; Josić D
    J Chromatogr A; 1999 Jun; 844(1-2):119-28. PubMed ID: 10399328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X.
    Miletich JP; Broze GJ; Majerus PW
    Anal Biochem; 1980 Jul; 105(2):304-10. PubMed ID: 6161558
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of proteomics for validation of the isolation process of clotting factor IX from human plasma.
    Clifton J; Huang F; Gaso-Sokac D; Brilliant K; Hixson D; Josic D
    J Proteomics; 2010 Jan; 73(3):678-88. PubMed ID: 19819359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heat inactivation of human immunodeficiency virus in lyophilized anti-inhibitor coagulant complex (Autoplex).
    Piszkiewicz D; Thomas W; Lieu M; Cabradilla CD; Andrews J; Kim J; Bourret E; McDougal JS; Cort SP
    Thromb Res; 1986 Dec; 44(5):701-7. PubMed ID: 3492776
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel one-step purification of mouse factor IX.
    Pilli VS; Plautz WE; Monroe DM; Majumder R
    Thromb Res; 2016 Mar; 139():125-6. PubMed ID: 26916308
    [No Abstract]   [Full Text] [Related]  

  • 35. Purification of human factor IX by chromatography of a coagulation factor concentrate.
    Suomela H
    Thromb Haemost; 1976 Feb; 35(1):211-21. PubMed ID: 989188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of an abnormal factor IX (Christmas factor) molecule. Factor IX Chapel Hill.
    Chung KS; Madar DA; Goldsmith JC; Kingdon HS; Roberts HR
    J Clin Invest; 1978 Nov; 62(5):1078-85. PubMed ID: 711853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihaemophilic factor (factor VIII) from human granulocytes.
    Szmitkowski M; Prokopowicz J; Szmitkowska K
    Haematologia (Budap); 1977; 11(1-2):177-87. PubMed ID: 27427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
    Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and properties of human factor IXa.
    Váradi K; Elödi S
    Thromb Haemost; 1976 Jun; 35(3):576-85. PubMed ID: 10636
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.